BACKGROUND: Candida bloodstream infections cause significant morbidity and mortality among hospitalized patients. Although clinical and microbiological factors affecting prognosis have been identified, the impact of genetic variation in the innate immune responses mediated by cytokines on outcomes of infection remains to be studied. METHODS: A cohort of 338 candidemia patients and 351 noninfected controls were genotyped for single-nucleotide polymorphisms (SNPs) in 6 cytokine genes (IFNG, IL10, IL12B, IL18, IL1β, IL8) and 1 cytokine receptor gene (IL12RB1). The association of SNPs with both candidemia susceptibility and outcome were assessed. Concentrations of pro- and antiinflammatory cytokines were measured in in vitro peripheral blood mononuclear cell stimulation assays and in serum from infected patients. RESULTS: None of the cytokine SNPs studied were associated with susceptibility to candidemia. Persistent fungemia occurred in 13% of cases. In the multivariable model, persistent candidemia was significantly associated with (odds ratio [95% confidence interval]): total parenteral nutrition (2.79 [1.26-6.17]), dialysis dependence (3.76 [1.46-8.64]), and the SNPs IL10 rs1800896 (3.45 [1.33-8.93]) and IL12B rs41292470 (5.36 [1.51-19.0]). In vitro production capacity of interleukin-10 and interferon-γ was influenced by these polymorphisms, and significantly lower proinflammatory cytokine concentrations were measured in serum from patients with persistent fungemia. CONCLUSIONS: Polymorphisms in IL10 and IL12B that result in low production of proinflammatory cytokines are associated with persistent fungemia in candidemia patients. This provides insights for future targeted management strategies for patients with Candida bloodstream infections.
BACKGROUND:Candida bloodstream infections cause significant morbidity and mortality among hospitalized patients. Although clinical and microbiological factors affecting prognosis have been identified, the impact of genetic variation in the innate immune responses mediated by cytokines on outcomes of infection remains to be studied. METHODS: A cohort of 338 candidemiapatients and 351 noninfected controls were genotyped for single-nucleotide polymorphisms (SNPs) in 6 cytokine genes (IFNG, IL10, IL12B, IL18, IL1β, IL8) and 1 cytokine receptor gene (IL12RB1). The association of SNPs with both candidemia susceptibility and outcome were assessed. Concentrations of pro- and antiinflammatory cytokines were measured in in vitro peripheral blood mononuclear cell stimulation assays and in serum from infected patients. RESULTS: None of the cytokine SNPs studied were associated with susceptibility to candidemia. Persistent fungemia occurred in 13% of cases. In the multivariable model, persistent candidemia was significantly associated with (odds ratio [95% confidence interval]): total parenteral nutrition (2.79 [1.26-6.17]), dialysis dependence (3.76 [1.46-8.64]), and the SNPs IL10rs1800896 (3.45 [1.33-8.93]) and IL12Brs41292470 (5.36 [1.51-19.0]). In vitro production capacity of interleukin-10 and interferon-γ was influenced by these polymorphisms, and significantly lower proinflammatory cytokine concentrations were measured in serum from patients with persistent fungemia. CONCLUSIONS: Polymorphisms in IL10 and IL12B that result in low production of proinflammatory cytokines are associated with persistent fungemia in candidemiapatients. This provides insights for future targeted management strategies for patients with Candida bloodstream infections.
Authors: Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler Journal: Science Date: 2002-05-23 Impact factor: 47.728
Authors: Kevin W Garey; Milind Rege; Manjunath P Pai; Dana E Mingo; Katie J Suda; Robin S Turpin; David T Bearden Journal: Clin Infect Dis Date: 2006-05-16 Impact factor: 9.079
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: Chantal A A Van der Graaf; Mihai G Netea; Servaas A Morré; Martin Den Heijer; Paul E Verweij; Jos W M Van der Meer; Bart Jan Kullberg Journal: Eur Cytokine Netw Date: 2006-03 Impact factor: 2.737
Authors: Gary M Hunninghake; Manuel E Soto-Quirós; Jessica Lasky-Su; Lydiana Avila; Ngoc P Ly; Catherine Liang; Barbara J Klanderman; Benjamin A Raby; Diane R Gold; Scott T Weiss; Juan C Celedón Journal: J Allergy Clin Immunol Date: 2008-04-28 Impact factor: 10.793
Authors: Tobias Woehrle; Weidong Du; Achim Goetz; Hsin-Yun Hsu; Thomas O Joos; Manfred Weiss; Ute Bauer; Uwe B Brueckner; E Marion Schneider Journal: Cytokine Date: 2008-01-30 Impact factor: 3.861
Authors: Theo S Plantinga; Melissa D Johnson; William K Scott; Leo A B Joosten; Jos W M van der Meer; John R Perfect; Bart Jan Kullberg; Mihai G Netea Journal: Med Mycol Date: 2012-06-04 Impact factor: 4.076
Authors: S P Smeekens; R K Malireddi; T S Plantinga; K Buffen; M Oosting; L A B Joosten; B J Kullberg; J R Perfect; W K Scott; F L van de Veerdonk; R J Xavier; E van de Vosse; T-D Kanneganti; M D Johnson; M G Netea Journal: Eur J Clin Microbiol Infect Dis Date: 2013-11-08 Impact factor: 3.267
Authors: J ten Oever; E J Giamarellos-Bourboulis; F L van de Veerdonk; F F Stelma; A Simon; M Janssen; M Johnson; A Pachot; B-J Kullberg; L A B Joosten; M G Netea Journal: Eur J Clin Microbiol Infect Dis Date: 2013-07-05 Impact factor: 3.267
Authors: C B Lupiañez; L M Canet; A Carvalho; L Alcazar-Fuoli; J Springer; M Lackner; J Segura-Catena; A Comino; C Olmedo; R Ríos; A Fernández-Montoya; M Cuenca-Estrella; C Solano; M Á López-Nevot; C Cunha; A Oliveira-Coelho; T Villaescusa; L Fianchi; J M Aguado; L Pagano; E López-Fernández; L Potenza; M Luppi; C Lass-Flörl; J Loeffler; H Einsele; L Vazquez; M Jurado; J Sainz Journal: Infect Immun Date: 2015-12-14 Impact factor: 3.441